Bionano Genomics Stock on Offer in IPO

If you’ve been an Illumina (ILMN) investor for a while, you have to be stoked about how well your investment has performed. This is a company that has an 80% market share selling machines that are the “picks and shovels” of the growing genomics market. More than half of the company’s revenues come from “consumables”, in other words, they don’t just make money selling their sequencing machines but also from recurring revenues once the machines are sold. And they’re selling like hotcakes:

Consequently, investors have increasingly high expectations of future performance based on how much shares have soared over the past years. Check out these returns:

	NASDAQ	AAPL	ILMN
5-